Clinical Trials Browser

Phase 2 × Locally Advanced Breast Cancer × Trastuzumab × Clear all

NCT03329378 2023-08-22

Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer

Phase 2 Terminated

7 enrolled 10 charts

Locally Advanced Breast Cancer